Literature DB >> 16705474

Tau haplotype affects CSF Tau levels in frontotemporal dementia: implication for diagnostic purposes.

B Borroni, M Di Luca, A Padovani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705474     DOI: 10.1007/s00415-006-0052-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Association between tau H2 haplotype and age at onset in frontotemporal dementia.

Authors:  Barbara Borroni; Despina Yancopoulou; Miho Tsutsui; Alessandro Padovani; Stephen J Sawcer; John R Hodges; Maria Grazia Spillantini
Journal:  Arch Neurol       Date:  2005-09

Review 2.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

Review 3.  Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders.

Authors:  E Vanmechelen; H Vanderstichele; F Hulstaert; N Andreasen; L Minthon; B Winblad; P Davidsson; K Blennow
Journal:  Mech Ageing Dev       Date:  2001-11       Impact factor: 5.432

4.  Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Authors:  M Riemenschneider; S Wagenpfeil; J Diehl; N Lautenschlager; T Theml; B Heldmann; A Drzezga; T Jahn; H Förstl; A Kurz
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

5.  Tau haplotypes regulate transcription and are associated with Parkinson's disease.

Authors:  John B J Kwok; Erdahl T Teber; Clement Loy; Marianne Hallupp; Garth Nicholson; George D Mellick; Daniel D Buchanan; Peter A Silburn; Peter R Schofield
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.